Search
Johnson & Johnson
JNJAdd to Watchlist
275.230USD
-3.200-1.15%
Close 09-04 16:00（ET）
662.84BMarket Cap
31.50P/E TTM
Revenue Breakdown
Currency: USDUpdated: Tue, Sep 1
Currency: USDUpdated: Tue, Sep 1
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
By BusinessUSD
Name
Revenue
Proportion
Oncology-DARZALEX
29.52B
0.00%
Immunology-TREMFYA
2.05B
8.08%
MedTech-Cardiovascular-ELECTROPHYSIOLOGY
1.53B
6.06%
MedTech-Surgery-General
1.46B
5.78%
MedTech-Surgery-Advanced
1.19B
4.70%
Other
-10.44B
75.38%
By RegionUSD
Name
Revenue
Proportion
United States
14.53B
57.42%
Europe
5.73B
22.62%
Asia-Pacific, Africa
3.74B
14.78%
Western Hemisphere, excluding U.S.
1.31B
5.17%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Oncology-DARZALEX
29.52B
0.00%
Immunology-TREMFYA
2.05B
8.08%
MedTech-Cardiovascular-ELECTROPHYSIOLOGY
1.53B
6.06%
MedTech-Surgery-General
1.46B
5.78%
MedTech-Surgery-Advanced
1.19B
4.70%
Other
-10.44B
75.38%